Virus-Immunotherapy combo takes on tough cancers
Disease control
Ongoing
This study tests a new combination treatment for people with advanced solid tumors, including non-small cell lung cancer, neuroendocrine cancer, and kidney cancer. The treatment uses a modified virus (VSV-IFNβ-NIS) plus an immunotherapy drug (pembrolizumab) to help the immune sys…
Phase: PHASE1, PHASE2 • Sponsor: Vyriad, Inc. • Aim: Disease control
Last updated Jun 12, 2026 12:03 UTC